Last reviewed · How we verify

NCT07261280

Testing a Biometric Identification System to Improve Malaria Vaccine Completion

Recruiting now NA Last updated 3 December 2025
What this trial tests

NA trial testing HEALTH FACILITY INTERVENTION in Vaccination in 4,715 participants. Currently enrolling.

Timeline
15 October 2025
Primary endpoint
31 December 2027
31 December 2027

Quick facts

Lead sponsorUniversity of Michigan
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposehealth services research
Enrollment4,715
Start date15 October 2025
Primary completion31 December 2027
Estimated completion31 December 2027
Sites1 location across Ghana

Drugs / interventions tested

Conditions studied

Sponsor

University of Michigan

Who can join

Adults 15 to 49, female only, with Vaccination. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Receiving all four doses of the malaria vaccine can significantly protect children against malaria illness, hospitalization, and death. However, in Ghana, only 46% of children complete the full vaccination sequence. More broadly, many children in Ghana do not receive the full set of recommended pediatric vaccinations. To address this, Simprints, in collaboration with Ghana Health Services, will implement a digital vaccination record system linked to biometrics. This system will automatically identify children who are behind on their vaccination schedule, providing health workers with information to prioritize community outreach. Additionally, it will send voice message reminders to caregivers to improve compliance. A cluster-randomized controlled trial (c-RCT) will be conducted in the Oti region to measure the impact of this innovation on the proportion of children completing malaria and routine vaccination schedules.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Vaccination

Currently open trials in the same condition.

Other University of Michigan trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07261280.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing